[
  {
    "scenario_name": "Q4\u202f2025 Strategic Planning Offsite \u2013 NovaHealth Systems",
    "company_context": "NovaHealth Systems is a $2.3\u202fB digital\u2011health platform that delivers tele\u2011medicine, AI\u2011driven diagnostics, and remote\u2011patient\u2011monitoring solutions to health systems and employers in the US and Canada. The executive team (CEO, CFO, COO, CMO, CTO, CPO, CSO, VP of Sales, VP of Engineering, VP of Customer Success) meets annually for a three\u2011day offsite to set the 3\u2011year strategic direction and FY26 OKRs.",
    "meeting_event_details": "September\u202f9\u201111\u202f2025 (Thursday\u2011Saturday), 08:30\u201118:30 each day, with evening networking on Sep\u202f9\u201110. Location: The Lodge at Aspen, Colorado (mountain resort conference center, 30\u2011person breakout rooms, high\u2011speed Wi\u2011Fi). External facilitator: Dr. Maya Patel (Strategic Horizons).",
    "stakeholders": [
      "Laura Chen \u2013 Chief Executive Officer (overall vision, final decision authority)",
      "David Alvarez \u2013 Chief Financial Officer (budget, capital allocation)",
      "Sofia Martinez \u2013 Chief Operating Officer (execution roadmap, org design)",
      "Dr. Ethan Patel \u2013 Chief Medical Officer (clinical strategy, regulatory impact)",
      "Ravi Singh \u2013 Chief Technology Officer (AI platform roadmap, tech debt)",
      "Megan O'Leary \u2013 Chief Product Officer (product portfolio prioritization)",
      "Natalie Brooks \u2013 Chief Strategy Officer (facilitates scenario planning, competitive analysis)",
      "James Liu \u2013 VP of Sales (go\u2011to\u2011market, partnership strategy)",
      "Olivia Grant \u2013 VP of Engineering (resource planning, delivery cadence)",
      "Carlos Reyes \u2013 VP of Customer Success (NPS trends, retention strategy)",
      "Dr. Maya Patel \u2013 External Facilitator (process design, decision\u2011making framework)"
    ],
    "deliverables": [
      "Approved Strategic Priority Matrix (AI diagnostics, International expansion, Partnership ecosystem)",
      "FY26 OKR Sheet (company\u2011wide objectives with measurable key results)",
      "Capital Allocation Plan (R&D $80\u202fM, Acquisitions $40\u202fM, Market expansion $30\u202fM)",
      "Revised Vision & Mission Statements",
      "12\u2011Month Execution Roadmap (milestones, owners, timelines)",
      "Risk Register and Mitigation Plan",
      "Offsite Summary Deck (to be sent to Board within 5\u202fdays)",
      "Company\u2011wide Communication Playbook (press release, internal rollout, town\u2011hall agenda)"
    ],
    "success_criteria": [
      "Post\u2011offsite alignment survey average score \u2265\u202f85\u202f% across executives",
      "Facilitator evaluation rating \u2265\u202f4.5\u202f/\u202f5",
      "Board approval of FY26 OKRs and capital plan by Oct\u202f5\u202f2025",
      "All deliverables completed and distributed within the defined timelines",
      "Actionable 12\u2011month roadmap with \u2265\u202f90\u202f% of milestones assigned to owners"
    ],
    "constraints": [
      "Offsite limited to 3\u202ffull days (72\u202fperson\u2011hours total)",
      "Offsite budget capped at $120,000 (venue, travel, facilitator fees)",
      "Key pre\u2011work (market research, financial analysis) must be submitted by Aug\u202f15\u202f(T\u201130)",
      "Decisions must be finalized before the Board meeting on Oct\u202f5\u202f2025",
      "Travel restrictions: all participants must have COVID\u201119 vaccination proof and negative test within 48\u202fhours of departure"
    ],
    "workback_prompt": "Generate a detailed work\u2011back plan for NovaHealth Systems' Q4\u202f2025 Strategic Planning Offsite (September\u202f9\u201111, 2025, Aspen). Include all pre\u2011work (market research, financial analysis), facilitator preparation, agenda finalization, logistics (travel, lodging, tech setup), day\u2011by\u2011day session plans, decision\u2011making checkpoints, post\u2011offsite deliverable production, and communication rollout. Align tasks with the constraints (T\u201190 horizon, $120k budget, pre\u2011work due Aug\u202f15, Board approval by Oct\u202f5) and map each deliverable to a responsible owner and due date. Provide the plan in a table format suitable for a project\u2011management tool.",
    "meeting_type": "Strategic Planning Offsite",
    "meeting_type_key": "9_strategic_offsite",
    "scenario_number": 1,
    "horizon": "T-90",
    "complexity": "Very High",
    "generated_at": "2025-11-17T07:26:37.814573"
  },
  {
    "scenario_name": "Apex BioSolutions \u2013 2025 Strategic Planning Offsite",
    "company_context": "Apex BioSolutions is a fast\u2011growing, publicly\u2011traded biotech company (NASDAQ: APXB) focused on next\u2011generation cell\u2011based immunotherapies for oncology and autoimmune diseases. The firm has $1.2\u202fB in annual revenue, $850\u202fM in cash, and a pipeline that includes two FDA\u2011approved CAR\u2011T products and three candidates in Phase\u202f2. The executive team is preparing the 2025\u20112027 strategic plan to decide on a new CAR\u2011NK platform, allocate a $200\u202fM R&D budget, and set company\u2011wide OKRs aligned with a five\u2011year vision of becoming the market leader in off\u2011the\u2011shelf cell therapies.",
    "meeting_event_details": "Dates: Thursday\u202fJune\u202f10\u202f2025\u202f\u2013\u202fSaturday\u202fJune\u202f12\u202f2025 (3\u202fdays). Time: 8:30\u202fam\u202f\u2013\u202f5:30\u202fpm each day, with a half\u2011day off on Saturday (8:30\u202fam\u202f\u2013\u202f12:30\u202fpm). Location: The Lodge at Snowy River, 1450 Aspen Road, Aspen, Colorado (full\u2011board resort with conference facilities, high\u2011speed Wi\u2011Fi, and breakout rooms). The agenda includes market trend deep\u2011dives, competitive landscape workshops, visioning sessions, OKR formulation, and decision\u2011making panels.",
    "stakeholders": [
      "Dr. Elena Martinez \u2013 Chief Executive Officer (overall sponsor, final decision authority)",
      "James Liu \u2013 Chief Financial Officer (budget oversight, financial modeling)",
      "Dr. Priya Nair \u2013 Chief Medical Officer (pipeline and clinical strategy)",
      "Dr. Victor Chen \u2013 Chief Technology Officer (technology platform evaluation)",
      "Laura Patel \u2013 Chief Revenue Officer (commercial strategy, market access)",
      "Megan O'Connor \u2013 Chief Human Resources Officer (talent and organization design)",
      "Ravi Desai \u2013 Chief Strategy Officer (facilitates internal sessions, owns OKR framework)",
      "Maya Patel \u2013 Lead Facilitator, Strategic Edge Consulting (external facilitator, neutral process owner)",
      "External Advisors: Dr. Susan Kline (Regulatory), Mark Reynolds (M&A), and Karen Brooks (Payer & Reimbursement)",
      "Board Liaison: Thomas Greene \u2013 Corporate Secretary (ensures alignment with board expectations)"
    ],
    "deliverables": [
      "Executive Summary Deck (10\u2011slide) capturing vision, strategic priorities, and OKRs",
      "Detailed 3\u2011Year Financial Model (2025\u20112027) with scenario analysis for new CAR\u2011NK platform",
      "Competitive Landscape Matrix (incl. 12 global rivals, SWOT, market share forecasts)",
      "R&D Portfolio Allocation Plan (budget split, milestones, go/no\u2011go gates)",
      "Partnership & M&A Playbook (target criteria, deal pipeline, integration roadmap)",
      "Action\u2011Item Tracker (owner, due date, KPI) for all decisions made",
      "Board Briefing Package (full report + Q&A FAQ) to be delivered within 5\u202fbusiness days"
    ],
    "success_criteria": [
      "All 5 strategic priorities are defined, ranked, and assigned owners by end of day\u202f2",
      "Consensus on 2025\u20112026 OKRs achieved with \u226590\u202f% alignment score in post\u2011session survey",
      "Decision on CAR\u2011NK platform (go/no\u2011go) documented with supporting financial model and risk register",
      "R&D budget allocation approved and signed off by CFO and CEO before day\u202f3 close",
      "Post\u2011offsite communication plan executed: executive summary sent to Board within 48\u202fhours, town\u2011hall scheduled within 2\u202fweeks, and action\u2011item tracker shared with all owners within 24\u202fhours"
    ],
    "constraints": [
      "Total offsite budget capped at $150\u202fK (venue, travel, facilitator fees, materials)",
      "All pre\u2011work (market research, financial analysis, customer insights) must be submitted to the facilitator by May\u202f28\u202f2025",
      "Key external advisors have limited availability \u2013 must be scheduled for 2\u2011hour slots on June\u202f10 and\u202f11",
      "Regulatory compliance: any discussion of unpublished data must be marked confidential and stored on encrypted drives",
      "Travel restrictions: all attendees must have COVID\u201119 vaccination proof and negative test within 72\u202fhours of departure"
    ],
    "workback_prompt": "Generate a detailed work\u2011back plan for the Apex BioSolutions 2025 Strategic Planning Offsite (June 10\u201112, 2025, Aspen, CO). Include all pre\u2011work deliverables (market research, financial models, SWOT, customer insights), facilitator preparation, agenda\u2011by\u2011hour, logistics (travel, lodging, tech setup), decision\u2011gate reviews, post\u2011offsite communication (Board brief, town\u2011hall, action\u2011item tracker), and risk mitigation steps. Align tasks with the constraints (budget $150K, pre\u2011work deadline May 28, external advisor availability) and success criteria (priority definition, OKR consensus, CAR\u2011NK decision, budget sign\u2011off, communication rollout). Output a timeline with owners, due dates, dependencies, and required resources.",
    "meeting_type": "Strategic Planning Offsite",
    "meeting_type_key": "9_strategic_offsite",
    "scenario_number": 2,
    "horizon": "T-90",
    "complexity": "Very High",
    "generated_at": "2025-11-17T07:36:30.335588"
  },
  {
    "scenario_name": "Helios BioTech FY26 Strategic Planning Offsite",
    "company_context": "Helios BioTech, a $1.2B publicly\u2011traded biotechnology company focused on next\u2011generation gene\u2011editing therapies for rare genetic disorders. The executive team includes the CEO, CFO, COO, CMO, CRO, Chief Strategy Officer, VP of R&D, VP of Commercial, and CHRO. The offsite is the first full\u2011team strategic planning session since the Series\u202fD financing round and will set the direction for FY26 and beyond.",
    "meeting_event_details": "June 10\u201112, 2025 (3 days). Arrival & welcome dinner June\u202f10 at 6:00\u202fPM, full agenda runs 8:30\u202fAM\u20135:30\u202fPM each day. Location: Aspen Mountain Resort, Aspen, Colorado (Conference Center\u202fA, rooms 101\u2011104, plus breakout spaces). All meals, transportation from Denver International Airport, and a one\u2011night team\u2011building ski activity are included.",
    "stakeholders": [
      "Dr. Elena Ramirez \u2013 Chief Executive Officer (overall sponsor, final decision\u2011maker)",
      "James Liu \u2013 Chief Financial Officer (budget, capital allocation)",
      "Maya Patel \u2013 Chief Operating Officer (execution roadmap)",
      "Dr. Priya Nair \u2013 Chief Medical Officer (pipeline prioritization)",
      "Dr. Carlos Ortega \u2013 Chief Research Officer (R&D strategy)",
      "Laura Chen \u2013 Chief Commercial Officer (market entry & partnership strategy)",
      "Sanjay Patel \u2013 Chief Strategy Officer (facilitates scenario planning)",
      "Aisha Khan \u2013 Chief Human Resources Officer (talent & culture alignment)",
      "Dr. Maya Patel \u2013 External Facilitator, Senior Partner, StrategyBridge (neutral process owner)",
      "External Advisors: Dr. Robert Stein (Regulatory), Ms. Vanessa Brooks (M&A counsel)"
    ],
    "deliverables": [
      "Executive Summary Deck (10 slides) outlining FY26 vision, strategic priorities, and OKRs",
      "Capital Allocation Model showing $200M investment plan across R&D, commercialization, and M&A",
      "Go/No\u2011Go decision matrix for Phase\u202fIII trial of Hemophilia\u2011B gene therapy",
      "Competitive Landscape Heatmap with 5\u2011year trend projections",
      "Revised 5\u2011Year Vision Statement and Mission Alignment Document",
      "Action\u2011Item Register with owners, milestones, and owners for each strategic initiative",
      "Communication Playbook for post\u2011offsite rollout (board brief, employee town\u2011hall, investor update)"
    ],
    "success_criteria": [
      "All FY26 OKRs are defined, quantified, and assigned to owners within 48\u202fhours of the offsite",
      "Capital allocation model approved by CFO and board liaison by end of day 3",
      "Phase\u202fIII go/no\u2011go decision documented and signed off by CEO and CRO",
      "Strategic partnership shortlist (minimum 3 candidates) agreed upon with evaluation criteria",
      "Post\u2011offsite communication plan executed: board brief sent within 24\u202fhours, employee town\u2011hall scheduled within 5 business days, investor update drafted within 7 days",
      "Participant satisfaction \u2265\u202f90\u202f% (post\u2011event survey) and perceived clarity of direction \u2265\u202f8/10"
    ],
    "constraints": [
      "Total offsite budget capped at $250,000 (venue, travel, facilitation, materials)",
      "All pre\u2011work (market research, financial analysis, competitor dossiers) must be submitted to the facilitator by May\u202f20,\u202f2025",
      "Regulatory filing deadlines (e.g., IND amendment due July\u202f15) limit the amount of time that can be allocated to new trial design discussions",
      "Key external advisors (Regulatory, M&A counsel) are only available for 4\u202fhours total across the three days",
      "COVID\u201119 travel restrictions require all participants to be fully vaccinated and present a negative test within 72\u202fhours of arrival"
    ],
    "workback_prompt": "Create a detailed work\u2011back plan for the Helios BioTech FY26 Strategic Planning Offsite (June\u202f10\u201112,\u202f2025). Include all pre\u2011work deliverables (market research, financial models, competitor analysis), facilitator preparation, logistics (travel, venue booking, catering), agenda development, breakout session planning, decision\u2011making checkpoints, post\u2011offsite communication rollout, and risk mitigation steps. Provide timelines, owners, dependencies, and milestones leading up to the offsite and through the first 30\u202fdays after the event, ensuring the success criteria and constraints listed in the scenario are met.",
    "meeting_type": "Strategic Planning Offsite",
    "meeting_type_key": "9_strategic_offsite",
    "scenario_number": 3,
    "horizon": "T-90",
    "complexity": "Very High",
    "generated_at": "2025-11-17T07:46:20.308917"
  }
]